Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silke Lassmann

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
The Journal of Pathology|September 24, 2017
A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasionChristiane Daniela Fichter, Camilla Maria Przypadlo, Achim Buck, et al.
Journal of Neuro-Oncology|April 29, 2018
MR-spectroscopic imaging of glial tumors in the spotlight of the 2016 WHO classificationElie Diamandis, Carl Phillip Simon Gabriel, Urs Würtemberger, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 24, 2008
Chromosomal changes characterize head and neck cancer with poor prognosisVerena L Bauer, Herbert Braselmann, Michael Henke, et al.
Molecular Oncology|October 4, 2014
SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancerKerstin Rönsch, Sabine Jägle, Katja Rose, et al.
International Journal of Cancer|February 11, 2014
EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancerChristiane Daniela Fichter, Sylvia Timme, Julia Alexandra Braun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Significance of HER2 low-level copy gain in Barrett's cancer: implications for fluorescence in situ hybridization testing in tissuesSandra Rauser, Roland Weis, Herbert Braselmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancerSabine Jägle, Kerstin Rönsch, Sylvia Timme, et al.
Proteomics. Clinical Applications|June 4, 2014
Impact of routinely employed procedures for tissue processing on the proteomic analysis of formalin-fixed paraffin-embedded tissuePeter Bronsert, Juliane Weißer, Martin L Biniossek, et al.
Molecular and Cellular Pediatrics|April 13, 2026
Efficacy of azacitidine and trametinib against leptomeningeal melanosis associated with congenital melanocytic nevus syndromeLina Raljević, Katalin Komlosi, Ursula Feige, et al.
Urologia Internationalis|April 16, 2024
Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor BoardJakob Michaelis, Ruth Himmelsbach, Patrick Metzger, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Pathology|September 24, 2017
A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasionChristiane Daniela Fichter, Camilla Maria Przypadlo, Achim Buck, et al.
Journal of Neuro-Oncology|April 29, 2018
MR-spectroscopic imaging of glial tumors in the spotlight of the 2016 WHO classificationElie Diamandis, Carl Phillip Simon Gabriel, Urs Würtemberger, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 24, 2008
Chromosomal changes characterize head and neck cancer with poor prognosisVerena L Bauer, Herbert Braselmann, Michael Henke, et al.
Molecular Oncology|October 4, 2014
SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancerKerstin Rönsch, Sabine Jägle, Katja Rose, et al.
International Journal of Cancer|February 11, 2014
EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancerChristiane Daniela Fichter, Sylvia Timme, Julia Alexandra Braun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Significance of HER2 low-level copy gain in Barrett's cancer: implications for fluorescence in situ hybridization testing in tissuesSandra Rauser, Roland Weis, Herbert Braselmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancerSabine Jägle, Kerstin Rönsch, Sylvia Timme, et al.
Proteomics. Clinical Applications|June 4, 2014
Impact of routinely employed procedures for tissue processing on the proteomic analysis of formalin-fixed paraffin-embedded tissuePeter Bronsert, Juliane Weißer, Martin L Biniossek, et al.
Molecular and Cellular Pediatrics|April 13, 2026
Efficacy of azacitidine and trametinib against leptomeningeal melanosis associated with congenital melanocytic nevus syndromeLina Raljević, Katalin Komlosi, Ursula Feige, et al.
Urologia Internationalis|April 16, 2024
Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor BoardJakob Michaelis, Ruth Himmelsbach, Patrick Metzger, et al.
Pageof 8